X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/intra-cellulars-caplyta-scores-again-second-major-depressive-disorder-trial
https://www.globenewswire.com/news-release/2024/06/18/2900311/30597/en/Intra-Cellular-Therapies-Announces-Positive-Topline-Results-in-Second-Phase-3-Trial-Evaluating-Lumateperone-as-Adjunctive-Therapy-in-Patients-with-Major-Depressive-Disorder.html
https://www.globenewswire.com/news-release/2024/06/10/2895965/30597/en/Intra-Cellular-Therapies-to-Present-at-the-45th-Annual-Goldman-Sachs-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/29/2889839/30597/en/Intra-Cellular-Therapies-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/23/2887220/30597/en/Intra-Cellular-Therapies-Highlights-Data-Presentations-at-the-American-Society-of-Clinical-Psychopharmacology-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/08/2877777/30597/en/Intra-Cellular-Therapies-to-Participate-in-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/07/2876619/30597/en/Intra-Cellular-Therapies-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/30/2872211/30597/en/Intra-Cellular-Therapies-to-Host-First-Quarter-2024-Financial-Results-Conference-Call-and-Webcast.html
https://www.globenewswire.com/news-release/2024/04/24/2869052/30597/en/Intra-Cellular-Therapies-Announces-Closing-of-575-Million-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://www.globenewswire.com/news-release/2024/04/18/2865054/30597/en/Intra-Cellular-Therapies-Prices-Public-Offering-of-Common-Stock.html
Market Place
Share 
